FDA Advisory Committee to Review Puma’s Request for Neratinib Approval
News
A U.S. Food and Drug Administration advisory committee will begin a review on May 24 of Puma Biotechnology‘s neratinib as a breast cancer treatment. If the independent Oncologic Drug Advisory Committee ... Read more